A Triple Combination Tailored Therapy (Folfiri-Cetuximab) for Safe Dose Intensification: A Multicenter Phase II Proof-Of-Concept Study.
Titel:
A Triple Combination Tailored Therapy (Folfiri-Cetuximab) for Safe Dose Intensification: A Multicenter Phase II Proof-Of-Concept Study.
Auteur:
Capitain, O. Metges, J.P. Boisdron-Celle, M. Adenis, A. Raoul, J.L. Lecomte, T. Lam, Y. Faroux, R. Masliah, C. Poirier, A.L. Berger, V. Morel, A. Gamelin, E.